Silver Nanoparticle as Antiviral Agent and Its Uses

Rajdeep Dutta, Sukhen Roy, Chandan Datta


Silver had been used by human thousands of years ago as various types of medicines (RasaratnaSamuccahay, Bhagbhatta). As the years passes more scientific uses of silver metals had been seen as the human civilization progresses.After the discovery of nano technology Silver is being used in a variety of ways .Nano particles exhibits less toxicity as compared to their ionic counterpart. Nowadays silver is used in various forms colloidal silver Nanoparticle (AgNPs) is one of the main form of silver, Today is being used in Human body considering toxicity level Colloidal Silver is being used as a new antimicrobial agent having broad microbial activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi (Nauran H Assar and Hayam M Hamuoda,2010). Domestic cleaning products enhanced with antimicrobial silver have been patented(Minner and Eatough 2007).Viral infections make disparateneed for the development of safe and potent alternatives to conventional antiviral drugs. In now days, nanoscale materials have emerged as novel antiviral agents for the enormous possibilities offered by their unique chemical and physical properties. Colloidal silver or silver nanoparticle has its own antimicrobial properties to combat all types of viruses including human immunodeficiency virus, hepatitis B virus, herpes simplex virus, flu virus etc. Our main focus through this review is to literate the people about this rediscovered material and it hasantimicrobial properties which will be very much helpful for the society in long run.


Antibacterial effect, antiviral agent, colloidal silver, nanotechnology, silver nanoparticles, immune booster

Full Text:



Brentano L, Margraf H, Monafo WW,NID Moyer CA. Antibacterial Efficacy of a Colloidal Silver Complex. Surgical Forum, Vol. 17, 1966, pp. 76–78.

JonesCatalina Marambio, Hoek Eric MV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment.Springer

MahamatiShreemadBagbhattacharya RasaratnaSamuchhaya

Assar Nauran H, HamuodaHayam M, Colloidal Silver as a New Antimicrobial Agent.(2010). International Journal of Microbial Research 1 (1): 33–36,2010.

Miner EO, CN Eatough (25 Dec. 2007). Antiseptic solutions containing silver chelated with polydentate and EDTA, U.S. Patent No. 7,311,927. U.S. Patent No. 7,311,927.

South, James, Electro-Colloidal Silver: The Amazing Anti-Microbial, Lecture given at Natural Products Expo West, Anaheim, 3/10/94. Available from Teamwork Marketing, PO Box 916, San Anselmo, CA 94979.

Moyasar TY, Landeen LK, Messina MC, Kurz SM, Schulze R, Gerba CP. Disinfection of bacteria in water systems by using electrolytically generated copper, silver and reduced levels of free chlorine. Found in Canadian Journal of Microbiology. The National Research Council of Canada: Ottawa, Ont., Canada, 1919, pp. 109–116.

Wijnhoven Susan WP et al.Nano-silver–a review of available data and knowledge gaps in human and environmental risk assessment.

Ibid., (Quoting from. the British Medical Journal. Jan. 15, 1917) p. 83.

Ibid., (Quoting Sir James Cantlie in the British Medical Journal, Nov. 15, 1913) p. 83.

Ibid., (Quoting J. Mark Hovell in the British Medical Journal, Dec. 15, 1917) p. 86.

Ibid., (Quoting J. MacMunn in the British Medical Journal, 1917, 1, 685) p, 36.

Ibid., (Quoting Sir Malcolm Morris in the British Medical Journal, May 12, L917) p. 35.

Ibid., (Quoting A. Legge Roe in the British Medical journal, Jan. 16, 1915) p. 83.

Searle AB. The Use of Colloids in Health and Disease. EP Dutton & Company: Now York, 1919, p.75.

Jim Powell. Our Mightiest Germ Fighter, Science Digest,March1978, p. 59–60. Kehoe RA et al. 1940. J. Nutt. t9. 579.

Voyutsky S. Colloid Chemistry, translated by N. Bobrov. Mir Publishers: Moscow, 1978, p. 21. Goddard ED.Colloid, The World Book Encyclopedia. World Book Inc.: Chicago, 1985, Vol. 4, p.623

Simonetri N, Simonetti G, Bougnol F, and Scaizo, M. Electrochemical AG+ for preservative use. Article found in Applied and Environmental Microbiology. American Society for Microbiology: Washington, v. 58, 12, 1992, pp. 3834–3836.

Slawson RM, Van Dyke MI Lee H, and Trevors JT. Germanium and silver resistance, accumulation, and toxicity in microorganisms. Article found in Plasmid. Academic Press, Inc.: San Diego, v.27, 1, 1992, 73–79.

Freundlich, H. The Elements of Colloidal Chemistry, translated by G. Barger. Methuen &Co. Ltd.: London, 1925, p. 13 1.

Hirschberg, Leonard Keene Electrical Colloids from an article out of John-, Hopkins Hospital. Kopaczewski, W. The Pharmacodynamics of Colloids, Colloid chemistry theoretical and applied, ed. J. Alexander, The Book Department, The Chemical Catalog, Company, Inc.: New York, Vol. 2, t928, p.962

Higher Education Library Publishers (H.E.L.P. full news), Colloidal Silver—A Closer Look., Vol. 9–11. Alexander, J. Colloid Chemistry. Van Nostrand Co.: New York, N.Y. 1924, p. 33.

NR Thompson. Comprehensive Inorganic Chemistry. Volume 5, chapter 28, Pergamon Press, Elmsford, New York. 1973.

Larry C. Ford, MD, Department of Obstetrics and Gynecology, UCLA School of Medicine, Center For The Health Sciences. 1988 letter available from Teamwork Marketing, PO Box 916, San Anselmo, CA94979.

East BW et al. Silver retention, Total Body Silver and Tissue Silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clinical and Experimental Dermatology. 1980. 5, 305–311.

Bechhold, H. Colloids in Biology and Medicine, translated by JGM Bullow, D. Van Nostrand Company: New York, 1919, p. 359.

Thurman RB, Gerba CP. The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses. A paper presented in the First International Conference on Gold and Silver in Medicine. The Silver Institute: Washington, 18, 4, 1989, p. 295.

Hartman RJ. Colloid Chemistry. Houghton Mifflin Company: Boston, 1939, p. 536

WR Hill, MD and DM Pillsbury, MA, MD. Argyria The Pharmacology of Silver. Williams & Wilkins Company, 1939.

Hauser EA. Colloidal Phenomena, an Introduction to the Science of Colloids. McGrawHill Book Company, Inc.: New York, 1939, pp. 59–73.

Tipton IH et al. 1966. Health Physics. 12. 1683.

Bechhold H. Colloids in biology and medicine, translated by JGM Builoow, D. Van Nostrand Company: New York, 1919, p. 367.

Ibid., p. 368.

Ibid., p. 299.

Searle AB. The use of colloids in health and disease. (Quoting from the British Medical journal, May 12, 1917) EP Dutton & Company: New York, 1919, p. 82.

Ibid., ( Quoting Henry Crookes) p. 70.

Ibid., (Quoting B. Seymour Jones) p. 86.

Ibid., (Quoting CEA MacLeod in Lancet, Feb. 3, 1912) p. 83.

Ibid., (QuotingIJ Simpson in Lancet, Dec. 12, 1914) pp. 71–72.

Ibid., (Quoting TH Anderson Wells in Lancet, Feb. 16, 1918) p. 85.

Index-catalogue of the Library of the Surgeon General's Office United States Army. United States

Ibid., p. 376.

Ibid., p. 300.

Ibid., p. 301



Copyright (c) 2020 Nano Trends-A Journal of Nano Technology & Its Applications